Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Atma Capital is an investment organization founded by a former partner of Kleiner Perkins Caufield Byers and the co-founder of Jack Ma's private equity fund. The team includes alumni from MIT and McKinsey, supported by a board of technology leaders from various deep tech sectors. They focus on investing in a healthier, smarter world.
Atma Capital invests in sectors such as AI, healthcare, biotech, and climate technology. They typically support companies that are advancing digital technology, sustainability, and data-driven life sciences. Their investment strategy emphasizes scientific advancements that tackle universal challenges.
Notable portfolio companies include SiPhox Health, which develops accessible diagnostics through at-home health test kits; Yuva Biosciences, focusing on anti-aging solutions via mitochondrial science; and Uplift, enhancing athletic performance using artificial intelligence. Other investments include Strand Therapeutics, working on programmable mRNA for curative therapies, Clerio Vision, improving vision care with femtosecond laser technology, and Window Therapeutics, which develops breakthrough treatments for cancer.
Submit through their form at atmacap.com or email info@atmacap.com with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.